Amlodipine/atorvastatin
 | |
 | |
| Combination of | |
|---|---|
| Amlodipine | Calcium channel blocker |
| Atorvastatin | Statin |
| Clinical data | |
| Trade names | Caduet, Envacar, others |
| AHFS/Drugs.com | Professional Drug Facts |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| (verify) | |
Amlodipine/atorvastatin, sold under the brand name Caduet among others, is a fixed-dose combination medication for the treatment of high cholesterol and high blood pressure. It contains a statin and a calcium channel blocker.[1][2]
Society and culture
Brand names
Amlodipine/atorvastatin is marketed under the brand name Caduet in the United States, Australia, and Russia, and Envacar in the Philippines.[3][4]
In some countries Caduet is marketed by Viatris after Upjohn was spun off from Pfizer.[5][6][7]
References
- ^ Curran MP (2010). "Amlodipine/Atorvastatin". Drugs. 70 (2). Springer Science+Business Media: 191–213. doi:10.2165/11204420-000000000-00000. ISSN 0012-6667. PMID 20108992. S2CID 209144335.
- ^ Devabhaktuni M, Bangalore S (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–87. doi:10.2147/vhrm.s3339. PMC 2686256. PMID 19475775.
- ^ "Caduet - Drugs.com". Archived from the original on 19 June 2014.
- ^ "Envacar - Drugs.com". Archived from the original on 20 June 2014.
- ^ "Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan". Pfizer. 16 November 2020. Retrieved 17 June 2024 – via Business Wire.
- ^ "Caduet". Pfizer. Retrieved 17 June 2024.
- ^ "Brands". Viatris. 16 November 2020. Retrieved 17 June 2024.
 | This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |